Detalhe da pesquisa
1.
ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse.
Clin Gastroenterol Hepatol;
2023 Nov 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37951560
2.
Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER).
Clin Gastroenterol Hepatol;
2023 Sep 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37743037
3.
Clinical Trial Design in Ulcerative Colitis: Interpreting Evolving Endpoints Based on Post Hoc Analyses of the Vedolizumab Phase 3 Trials GEMINI 1 and VISIBLE 1.
Crohns Colitis 360;
6(1): otad076, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38213631
4.
Safety, immunogenicity and dose ranging of a new Vi-CRM197 conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults.
PLoS One;
6(9): e25398, 2011.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21980445